Abstract: Described are DNA sequences encoding an E6 or E7 fusion protein of HPV, wherein said DNA sequences are characterized by a combination of the following features: original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, they contain a deletion resulting in the production of a truncated non-functional protein, and they encode a fusion partner which is a highly immunogenic polypeptide capable of enhancing the immunogenicity of the E6 or E7 protein in the mammalian host. Furthermore, the modified E6 or E7 protein encoded by said DNA sequences as well as expression vectors containing said DNA sequences are described as well as several uses of the these compounds.

Abstract: The invention relates to a method and an apparatus for measuring the position and the orientation of an interventional device within a magnetic resonance imaging apparatus, the magnetic resonance image apparatus providing a static magnetic field B0 and magnetic field gradients with known magnetic flux densities and directions. The invention includes attaching a Faraday sensor to the interventional device, the Faraday sensor being connected to an optical measuring device. The method also includes using the optical measuring device for measuring the rotation of the plane of polarization of linearly polarized light in the Faraday sensor, while exposing the interventional device: (i) to the static magnetic field B0, and (ii) to the field gradients in all three directions of space in addition to the static magnetic field B0.

Abstract: Described are DNA sequences encoding an E6 or E7 fusionprotein of HPV, wherein said DNA sequences are characterized by a combination of the following features: original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, they contain a deletion resulting in the production of a truncated non-functional protein, and they encode a fusionpartner which is a highly immunogenic polypeptide capable of enhancing the immunogenicity of the E6 or E7 protein in the mammalian host. Furthermore, the modified E6 or E7 protein encoded by said DNA sequences as well as expression vectors containing said DNA sequences are described as well as several uses of the these compounds.

Abstract: Treatment of brain tumors by a composition including parvovirus, e.g., parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. Also described is the use of a parvovirus for the preparation of a pharmaceutical composition for the treatment of a brain tumor. Tumors for which the compositions and methods of the invention have particular utility include glioma, medulloblastoma and meningioma.

Abstract: The present invention relates to an AAV DNA having helper virus sequences which are necessary for developing AAV viral particles, a system containing such a DNA and the use of both.

Abstract: What is described are compounds wherein R represents Br, I or R1—SO3, where R1 is an unsubstituted or substituted C1–C5-alkyl group, or an unsubstituted or substituted phenyl group; X is O or NR?, where R? is a usual protective group for N; and R? represents hydrogen, a halogen, such as F, Cl, and Br, a substituted or unsubstituted C1–C7-alkyl group, such as methyl and ethyl, a substituted or unsubstituted C2–C7-alkenyl group, or a substituted or unsubstituted C2–C7-alkynyl group.

Abstract: The present invention relates to an inhibitor protein of the wnt signal path, a DNA encoding such a protein and a process for the preparation of such a protein. In addition, this invention concerns the use of the DNA and the protein as well as antibodies directed against the protein.

Abstract: The invention relates to a collimator (1) for defining a beam of energetic rays (2) which is emitted from an essentially punctiform radiation source (3) and is oriented onto an object (1) to be treated. The collimator is especially used for the stereotactic conformation radiotherapy of tumors. The collimator (1) is embodied in such a way that an irregular object (4) can be scanned by rays (2, 2?) which are defined by an opening in the collimator. The invention also relates to a program for controlling the collimator. In order to define the contours (29, 29?, 29?) of the objects (4) to be irradiated in a simple but highly accurate manner, especially with a precise definition of the irradiation fields, the collimator comprises a plurality of different sized openings (5, 5? 5?). One of the openings (5, 5?, 5?) can be selectively displaced in a polydirectional manner on a strip (6) having a spherical surface, and the central axis (7) thereof is oriented towards the radiation source (3).

Abstract: The present invention relates to multivalent Fvantibody construct having at least four variable domains which are linked with each over via the peptide linkers 1, 2 and 3. The invention also concerns expression plasmids which code for such an Fvantibody construct and a method of producing the Fvantibody constructs as well as their use.

Abstract: The present invention relates to a method by which saccharide compounds can be prepared in a very easy way. This method comprises the steps of: (a) attaching at least one saccharide to a cyclic or acyclic diene, (b) reacting the saccharide-containing diene obtained in step (a) or a commercially available saccharide-containing diene with a dienophile by Diels-Alder reaction.

Abstract: A device for fluorescence correlation spectroscopy, especially for multicolor fluorescence correlation spectroscopy, in which light rays are focused in a transparent medium located in a sample vessel. Such device includes a vessel holder in which at least two sample vessels with a focussing reflecting bottom are provided, and a common cover for both sample vessels which is at least partly light-transmitting. In a preferred embodiment, a plunger with a light window facing the bottom is inserted into the sample vessel, and the quantity of transparent medium is selected so that the light window of the plunger is immersed in or wetted by the medium.

Abstract: The present invention relates to a method of detecting a causative agent of the so-called spontaneous early abortion by investigating patients' samples for the presence of adeno-associated virias DNA (AAV DNA), or AAV antigen or antibodies, preferably of the IgM type, directed to AAV. Furthermore, the present invention relates to antibodies suitable for said method.

Abstract: The present invention relates to a process for derivatizing supports on a carriers, wherein a functional group is activated on a support surface by reaction with an activating reagent and then reacted with an amine component. The invention also relates to a support with a dendrimer structure on its surface and to the use of a support that has been produced according to the invention for binding biopolymers.

Abstract: The application relates to compounds that are suitable as labelable precursors for synthesis of 3?-[18F]fluoro-3?-deoxythymidine and that have formula (1), in which R denotes triphenylmethyl, triphenylmethyl substituted in the phenyl group, trialkylmethyl, triphenylsilyl, triphenylsilyl substituted in the phenyl group, or trialkylsilyl, R? denotes R1—SO2, where R1 is an unsubstituted or substituted C1 to C5 alkyl or an unsubstituted or substituted phenyl, and R? denotes C2 to C10 alkyloxycarbonyl, with the exception of 3-N-Boc-1-(3-O-nosyl-5-O-trityl-2-deoxy-?-D-lyxofuranosy The application also relates to a method for preparation of these compounds and to the use of the same for synthesis of 3?-[18F]fluoro-3?-deoxythymidine.

Abstract: This invention relates to a conjugate which consists of an active substance and a native protein which is not regarded as exogenous and distinguish itself in that an intracellulary cleavable linker is present between the active substance and the protein. In addition, this invention concerns a process for the preparation of such a conjugate and its use.

Abstract: The invention relates to a method and an apparatus for measuring the position and the orientation of an interventional device within a magnetic resonance imaging apparatus, the magnetic resonance image apparatus providing a static magnetic field B0 and magnetic field gradients with known magnetic flux densities and directions. The invention includes attaching a Faraday sensor to the interventional device, the Faraday sensor being connected to an optical measuring device. The method also includes using the optical measuring device for measuring the rotation of the plane of polarization of linearly polarized light in the Faraday sensor, while exposing the interventional device: (i) to the static magnetic field B0, and (ii) to the field gradients in all three directions of space in addition to the static magnetic field B0.

Abstract: The present invention relates to an antibody active against a fusion polypeptide comprising a histidine portion, a process for the preparation thereof and its use.

Abstract: The present invention relates to an antibody active against a fusion polypeptide comprising a histidine portion, a process for the preparation thereof and its use.

Abstract: The invention relates to the use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in patients who suffer from a cancer which is to be treated by radiotherapy or chemotherapy.

Abstract: A phagemid has been constructed that expresses an antibody fused to coliphage pIII protein. The phagemid is suitable for selecting specific antibodies from large gene libraries with small quantities of antigen. The antibody-pIII gene can be strongly repressed, so that it allows antibody libraries to be amplified without the danger of deletion mutants predominating. After induction, large quantities of the fusion protein may be expressed.